Navigating the Treg Cell Therapy Lifecycle: From Cell Selection to Clinical Impact

1:01 pm - Tuesday 23rd March 2027

This workshop explores the critical stages of Treg cell therapy development, from cell sourcing and engineering through manufacturing, regulatory strategy, and clinical translation. Attendees will gain a holistic understanding of how decisions made across the development lifecycle influence therapeutic potency, scalability, and clinical success, while learning how leading organizations are addressing common bottlenecks on the path toward durable immune tolerance.

This session will:

  • Address key translational challenges across manufacturing, scalability, product characterization, and regulatory development to improve the path toward approval
  • Learn from emerging clinical experience to identify biomarkers of response, optimize patient selection, and accelerate the development of next-generation Treg therapies